Laxter Pharmaceuticals Private Limited, a under process of striking off private limited company, was established on 07 September 2018 in Hi-Way, Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999GJ2018PTC103970. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Sagar Pravinbhai Hirani (Director), Jagbir Singh (Director). Past directors included Rushikumarkanaiyalal Ribadiya, Namankumar Kanubhai Trapsia, Jagdish Pravinbhai Hirani. It holds ₹1.40 Cr open charges and ₹1.40 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 22 Mahesh Tenaments, Nr. Sahjanand Complex, Nr. Holy-Child-Sch. Thakkarbapa, Hi-Way, Ahmedabad, Gujarat, 382350.
U74999GJ2018PTC103970
103970
07 September 2018
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Under Process Of Striking Off
Explore comprehensive insights into Laxter Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sagar Pravinbhai Hirani | Director | 09 May 2019 | Current |
| Jagbir Singh | Director | 07 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Jan 2021 | Past |
| Pramod Abcsdd | Director | 22 Jan 2021 | Past |
| Pramod Abcsdd | Director | 22 Jan 2021 | Past |
| Pramod Abcsdd | Director | 22 Jan 2021 | Past |
| Pramod Abcsdd | Director | 31 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Laxter Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 62.43% decrease. The company also saw a substantial fall in profitability, with a 91.59% decrease in profit. The company's net worth moved up by a moderate rise of 4.89%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Laxter Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹14,000,000.00
₹14,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Nov 2021 | Hdfc Bank Limited | ₹7.00 M | Satisfied |
| 08 Oct 2021 | Hdfc Bank Limited | ₹7.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Laxter Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Laxter Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laxter Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 17 Nov 2021 via Charge ID 100505405 with Hdfc Bank Limited was fully satisfied on 29 Oct 2025. was completed.
A charge registered on 08 Oct 2021 via Charge ID 100504504 with Hdfc Bank Limited was fully satisfied on 29 Oct 2025. was recorded as a recent event.
Progress on Laxter Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Laxter Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 7.00 M with Charge ID 100505405 was registered on 17 Nov 2021. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 7.00 M with Charge ID 100504504 was registered on 08 Oct 2021. was completed.
The CIN of Laxter Pharmaceuticals Private Limited is U74999GJ2018PTC103970.
Laxter Pharmaceuticals Private Limited is headquartered at 22 Mahesh Tenaments, Nr. Sahjanand Complex, Nr. Holy-Child-Sch. Thakkarbapa, Hi-Way, Ahmedabad, Gujarat, 382350.
Laxter Pharmaceuticals Private Limited was incorporated on 07 September 2018.
The current directors of Laxter Pharmaceuticals Private Limited are
The primary industry of Laxter Pharmaceuticals Private Limited is Trade.
Laxter Pharmaceuticals Private Limited is unlisted.
The authorized capital of Laxter Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX